Skip to main content
Fig. 8 | Cancer Nanotechnology

Fig. 8

From: g-C3N4-based photoresponsive magnetic nanocatalyst drives type-I photodynamic therapy under visible light irradiation, boosting chemo/chemodynamic synergistic therapy of colon cancer

Fig. 8

CT26 spheroid growth profile under the influence of CDDP and CCFCA. A The volume of spheroids treated with free CDDP and CCFCA in the presence and absence of SMF and light irradiation. The diameter of at least 30 CT26 spheroids was determined from days 1–9. Evaluation of live B and C dead cells in treated spheroids after 9 days incubation. D Assessment of nanocomposite penetration into spheroids after 3 days of incubation. The emission of green fluorescence is related to acridine orange which stained viable cells and blue fluorescence is related to innate fluorescence emission of nanocomposite (Magnification 100×, Scale bar 200 µm)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us